The 5-year survival probability was 69 and 85% for MYH9-positive and -negative adenocarcinoma patients, respectively, and 43 and 74% for MYH9-positive and -negative squamous cell carcinoma patients, respectively. The gene discussed is MYH9; the disease is adenocarcinoma.